Vicore Pharma Holding AB Statistics
Total Valuation
VCRE has a market cap or net worth of $291.21 million. The enterprise value is $213.07 million.
| Market Cap | 291.21M |
| Enterprise Value | 213.07M |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VCRE has 282.45 million shares outstanding. The number of shares has increased by 19.76% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 282.45M |
| Shares Change (YoY) | +19.76% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 4.89% |
| Owned by Institutions (%) | 32.13% |
| Float | 200.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 759.39 |
| Forward PS | 3,686.98 |
| PB Ratio | 4.01 |
| P/TBV Ratio | 4.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 555.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.88, with zero debt.
| Current Ratio | 8.88 |
| Quick Ratio | 8.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.83% and return on invested capital (ROIC) is -45.48%.
| Return on Equity (ROE) | -68.83% |
| Return on Assets (ROA) | -41.10% |
| Return on Invested Capital (ROIC) | -45.48% |
| Return on Capital Employed (ROCE) | -76.17% |
| Weighted Average Cost of Capital (WACC) | 4.80% |
| Revenue Per Employee | $9,587 |
| Profits Per Employee | -$1.31M |
| Employee Count | 40 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, VCRE has paid $26,046 in taxes.
| Income Tax | 26,046 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.10 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 9.96 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 58.51 |
| Average Volume (20 Days) | 23,856 |
Short Selling Information
The latest short interest is 1,028, so 0.00% of the outstanding shares have been sold short.
| Short Interest | 1,028 |
| Short Previous Month | 9,857 |
| Short % of Shares Out | 0.00% |
| Short % of Float | 0.00% |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, VCRE had revenue of $383,476 and -$52.54 million in losses. Loss per share was -$1.93.
| Revenue | 383,476 |
| Gross Profit | 383,476 |
| Operating Income | -55.55M |
| Pretax Income | -52.52M |
| Net Income | -52.54M |
| EBITDA | n/a |
| EBIT | -55.55M |
| Loss Per Share | -$1.93 |
Balance Sheet
The company has $77.33 million in cash and no debt, with a net cash position of $77.33 million or $2.74 per share.
| Cash & Cash Equivalents | 77.33M |
| Total Debt | n/a |
| Net Cash | 77.33M |
| Net Cash Per Share | $2.74 |
| Equity (Book Value) | 72.67M |
| Book Value Per Share | 2.57 |
| Working Capital | 72.47M |
Cash Flow
| Operating Cash Flow | -49.56M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -49.56M |
| FCF Per Share | -$1.75 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -14,484.78% |
| Pretax Margin | -13,694.50% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VCRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -19.76% |
| Shareholder Yield | -19.76% |
| Earnings Yield | -18.58% |
| FCF Yield | -17.02% |
Analyst Forecast
The average price target for VCRE is $30.08, which is 189.23% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $30.08 |
| Price Target Difference | 189.23% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -8.41% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |